Third, while the study assessed the use of TNF inhibitors, other potential contributors to NAFLD, such as genetic predisposition, dietary habits, and physical activity levels, were not evaluated. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.